Exact Mass: 545.1897016
Exact Mass Matches: 545.1897016
Found 237 metabolites which its exact mass value is equals to given mass value 545.1897016,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Man(a3)Man(b4)GlcNAc
C20H35NO16 (545.1955750000001)
alpha-D-Galactosyl-N-acetyllactosamine
C20H35NO16 (545.1955750000001)
Doxorubicinol
Doxorubicinol belongs to the family of Anthracyclines. These are polyketides containing a tetracenequinone ring structure with a sugar attached by glycosidic linkage.
Lacto-N-triaose
C20H35NO16 (545.1955750000001)
Human beta-1,3-N-acetylglucosaminyltransferase 2 (beta3GnT2) converts lacto-N-triose II into lacto-N-tetraose and lacto-N-neotetraose. (PMID:16277601).
Lacto-N-triose I
C20H35NO16 (545.1955750000001)
Lacto-N-triose I is found in milk and milk products. Lacto-N-triose I is isolated from the partial acid hydrolysis of human milk. Isolated from the partial acid hydrolysis of human milk. Lacto-N-triose I is found in milk and milk products.
N-Acetylgalactosaminyl lactose
C20H35NO16 (545.1955750000001)
N-Acetylgalactosaminyl lactose is a trisaccharide obtained from bovine colostrum. A trisaccharide obtained from bovine colostrum
Doxorubicinol aglycone
Doxorubicinol aglycone is a metabolite of doxorubicin. Doxorubicin is a drug used in cancer chemotherapy. It is an anthracycline antibiotic, closely related to the natural product daunomycin, and like all anthracyclines, it works by intercalating DNA. Doxorubicin is commonly used in the treatment of a wide range of cancers, including hematological malignancies, many types of carcinoma, and soft tissue sarcomas. Doxorubicins most serious adverse effect is life-threatening heart damage. (Wikipedia)
alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-D-GlcNAc
C20H35NO16 (545.1955750000001)
Gal-alpha1,4Gal-beta1,4-GlcNAc
C20H35NO16 (545.1955750000001)
THOS Streptonigrin
6-O-[2-Acetamido-2-deoxy-4-O-(b-D-galactopyranosyl)-b-D-glucopyranosyl]-D-galactopyranose
C20H35NO16 (545.1955750000001)
O3-(2-acetylamino-O3-beta-D-galactopyranosyl-2-deoxy-beta-D-glucopyranosyl)-D-galactose|O3-(2-Acetylamino-O3-beta-D-galactopyranosyl-2-desoxy-beta-D-glucopyranosyl)-D-galactose
C20H35NO16 (545.1955750000001)
N-Ac-2-Amino-2-deoxy-beta-D-glucopyranosyl-(1?3)-beta-D-galactopyranosyl-(1?4)-D-glucose
C20H35NO16 (545.1955750000001)
Cys Phe Asn Tyr
Cys Phe Tyr Asn
Cys Asn Phe Tyr
Cys Asn Tyr Phe
Cys Tyr Phe Asn
Cys Tyr Asn Phe
Phe Cys Asn Tyr
Phe Cys Tyr Asn
Phe Asn Cys Tyr
Phe Asn Tyr Cys
Phe Tyr Cys Asn
Phe Tyr Asn Cys
Asn Cys Phe Tyr
Asn Cys Tyr Phe
Asn Phe Cys Tyr
Asn Phe Tyr Cys
Asn Tyr Cys Phe
Asn Tyr Phe Cys
Tyr Cys Phe Asn
Tyr Cys Asn Phe
Tyr Phe Cys Asn
Tyr Phe Asn Cys
Tyr Asn Cys Phe
Tyr Asn Phe Cys
Lacto-N-triaose
C20H35NO16 (545.1955750000001)
Doxorubicinol
A member of the class of tetracenequinones that is the major metabolite of the anthracycline doxorubicin, a chemotherapeutic agent effective against a broad range of malignant neoplasms. It is thought to exhibit cardiotoxic properties.
Lacto-N-triose I
C20H35NO16 (545.1955750000001)
N-Acetylgalactosaminyl lactose
C20H35NO16 (545.1955750000001)
4-O-(6-O-[2-Acetamido-2-deoxy-b-D-glucopyranosyl]-b-D-galactopyranosyl)-D-glucopyranose
C20H35NO16 (545.1955750000001)
betaLacNAc
C20H35NO16 (545.1955750000001)
Sufrexal
C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist Ketanserin (R41468) tartrate is a selective 5-HT2 receptor antagonist. Ketanserin tartrate also blocks hERG current (IhERG) in a concentration-dependent manner (IC50=0.11 μM).
4-nitrophenyl 2-acetamido-3-o-(2-acetamido-2-deoxy-b-d-glucopyranosyl)-2-deoxy-a-d-galactopyranoside
4-Nitrophenyl 2-acetamido-6-O-(2-acetamido-2-deoxy-β-D-glucopyranosyl)-2-deoxy-α-D-galactopyranoside
O-2-(Acetylamino)-2-deoxy-beta-D-galactopyranosyl-(1-4)-O-alpha-D-galactopyranosyl-(1-4)-D-glucose
C20H35NO16 (545.1955750000001)
alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-D-GlcNAc
C20H35NO16 (545.1955750000001)
N-[(2S,3R,4R,5S,6R)-5-hydroxy-6-(hydroxymethyl)-2-[(2S,3R,4S,5S,6R)-2,3,5-trihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-4-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-3-yl]acetamide
C20H35NO16 (545.1955750000001)
beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->6)-D-Gal
C20H35NO16 (545.1955750000001)
alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-D-GlcNAc
C20H35NO16 (545.1955750000001)
alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-D-GlcNAc
C20H35NO16 (545.1955750000001)
alpha-D-galactosyl-(1,3)-beta-D-galactosyl-(1,4)-N-acetyl-D-glucosamine
C20H35NO16 (545.1955750000001)
beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->2)-alpha-D-Manp
C20H35NO16 (545.1955750000001)
N-[(2S,3R,4R,5S,6R)-2-[(2S,3S,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-[[(2R,3S,4S,5S,6R)-3,4,5,6-tetrahydroxyoxan-2-yl]methoxy]oxan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide
C20H35NO16 (545.1955750000001)
beta-D-Galp-(1->3)-beta-D-Galp-(1->4)-beta-D-GlcpNAc
C20H35NO16 (545.1955750000001)
alpha-D-Man-(1->3)-beta-D-Man-(1->4)-beta-D-GlcNAc
C20H35NO16 (545.1955750000001)
4-[(2E)-2-[(3-Methyl-1-phenyl-5-pyrrolidin-1-ylpyrazol-4-yl)methylidene]hydrazinyl]-3-nitro-N-phenylbenzenesulfonamide
C27H27N7O4S (545.1845142000001)
N-[(2S,3R,4R,5S,6R)-2-[(2R,3S,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-[(2R,3S,4S,5R,6R)-2,3,5-trihydroxy-6-(hydroxymethyl)oxan-4-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide
C20H35NO16 (545.1955750000001)
N-[(2S,3R,4R,5S,6R)-2-[(2R,3S,4R,5S,6R)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2R,3S,4S,5R,6R)-2,3,5-trihydroxy-6-(hydroxymethyl)oxan-4-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide
C20H35NO16 (545.1955750000001)
N-[(2R,3R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-[[(2R,3R,4S,5R,6S)-3,4,5-trihydroxy-6-[(2R,3S,4R,5R,6R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-2-yl]methoxy]oxan-3-yl]acetamide
C20H35NO16 (545.1955750000001)
N-acetyl-alpha-D-galactosaminyl-(1->3)-beta-D-galactosyl-(1->4)-D-glucose
C20H35NO16 (545.1955750000001)
beta-D-galactopyranosyl-(1->4)-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1->6)-D-mannopyranose
C20H35NO16 (545.1955750000001)
beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-D-Gal
C20H35NO16 (545.1955750000001)
alpha-D-galactosyl-(1->3)-alpha-D-galactosyl-(1->4)-N-acetyl-D-glucosamine
C20H35NO16 (545.1955750000001)
beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->6)-beta-D-galactose
C20H35NO16 (545.1955750000001)
beta-D-Glcp-(1->6)-beta-D-GlcpNAc-(1->3)-beta-D-Galp
C20H35NO16 (545.1955750000001)
alpha-D-Gal-(1->4)-beta-D-Gal-(1->3)-alpha-D-GalNAc
C20H35NO16 (545.1955750000001)
beta-D-Galp-(1->4)-beta-D-Glcp-(1->6)-beta-D-GlcpNAc
C20H35NO16 (545.1955750000001)
alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-NHAc
C20H35NO16 (545.1955750000001)
alpha-D-Gal-(1->3)-beta-D-Gal-(1->3)-beta-D-GlcNAc
C20H35NO16 (545.1955750000001)
(3R,3R,4S,6R,8S,8aS)-6-(4-hydroxyphenyl)-1,2-dioxo-3,4-diphenyl-8-spiro[1H-indole-3,7-4,6,8,8a-tetrahydro-3H-pyrrolo[2,1-c][1,4]oxazine]carboxamide
alpha-D-Galp-(1->4)-beta-D-GalpNAc-(1->4)-D-Galp
C20H35NO16 (545.1955750000001)
alpha-D-Galp-(1->4)-beta-D-Galp-(1->4)-D-GalpNAc
C20H35NO16 (545.1955750000001)
N-acetyl-beta-D-glucosaminyl-(1->4)-alpha-D-galactosyl-(1->3)-D-galactose
C20H35NO16 (545.1955750000001)
D-galacto-hexopyranosyl-(1->4)-2-acetamido-2-deoxy-D-gluco-hexopyranosyl-(1->2)-D-manno-hexopyranose
C20H35NO16 (545.1955750000001)
D-galacto-hexopyranosyl-(1->4)-2-acetamido-2-deoxy-D-gluco-hexopyranosyl-(1->2)-beta-D-manno-hexopyranose
C20H35NO16 (545.1955750000001)
D-galacto-hexopyranosyl-(1->4)-2-acetamido-2-deoxy-D-gluco-hexopyranosyl-(1->2)-alpha-D-manno-hexopyranose
C20H35NO16 (545.1955750000001)
2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->3)-beta-D-galactopyranosyl-(1->4)-D-glucopyranose
C20H35NO16 (545.1955750000001)
A linear amino trisaccharide comprising of 2-acetamido-2-deoxy-beta-D-glucopyranosyl residue (1->3)-linked to a beta-D-galactosyl residue, which is in turn linked (1->4) to D-glucose.